Cell Reports (Aug 2019)

MAVS O-GlcNAcylation Is Essential for Host Antiviral Immunity against Lethal RNA Viruses

  • Nan Song,
  • Qi Qi,
  • Ruiyuan Cao,
  • Bingjie Qin,
  • Bo Wang,
  • Yuxia Wang,
  • Lei Zhao,
  • Wei Li,
  • Xianli Du,
  • Feng Liu,
  • Yunzheng Yan,
  • Wen Yi,
  • Hailu Jiang,
  • Tao Li,
  • Tao Zhou,
  • Hui-yan Li,
  • Qing Xia,
  • Xue-min Zhang,
  • Wu Zhong,
  • Ai-ling Li,
  • Xiaotao Duan

Journal volume & issue
Vol. 28, no. 9
pp. 2386 – 2396.e5

Abstract

Read online

Summary: It is known that lethal viruses profoundly manipulate host metabolism, but how the metabolism alternation affects the immediate host antiviral immunity remains elusive. Here, we report that the O-GlcNAcylation of mitochondrial antiviral-signaling protein (MAVS), a key mediator of interferon signaling, is a critical regulation to activate the host innate immunity against RNA viruses. We show that O-GlcNAcylation depletion in myeloid cells renders the host more susceptible to virus infection both in vitro and in vivo. Mechanistically, we demonstrate that MAVS O-GlcNAcylation is required for virus-induced MAVS K63-linked ubiquitination, thereby facilitating IRF3 activation and IFNβ production. We further demonstrate that D-glucosamine, a commonly used dietary supplement, effectively protects mice against a range of lethal RNA viruses, including human influenza virus. Our study highlights a critical role of O-GlcNAcylation in regulating host antiviral immunity and validates D-glucosamine as a potential therapeutic for virus infections. : Mitochondrial antiviral-signaling protein (MAVS) plays a key role in host antiviral innate immunity. Song et al. demonstrate that O-GlcNAcylation of MAVS is critical in RNA virus-induced innate immune response and validate D-glucosamine as a potential broad-spectrum antiviral therapeutic. Keywords: MAVS, O-GlcNAcylation, glucosamine, RNA virus, influenza, interferon, antiviral immunity